| Titolo |
Pubblicato in |
Anno |
| Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy |
MOLECULES |
2024 |
| New Potent EV-A71 Antivirals Targeting Capsid. |
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY |
2024 |
| 4-(3-Phenylsulfonylindol-2-yl)-1-(pyridin-2-yl)piperazinyl-methanones as Potent Inhibitors of both SARS-CoV-2 and HCoV-OC43 Viruses |
ACS INFECTIOUS DISEASES |
2024 |
| Development of N-(4-(1 H-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability |
JOURNAL OF MEDICINAL CHEMISTRY |
2024 |
| Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 Infection |
CIRCULATION RESEARCH |
2023 |
| RS6077 induces mitotic arrest and selectively activates cell death in human cancer cell lines and in a lymphoma tumor in vivo |
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY |
2023 |
| A Novel Validated UHPLC Method for the Estimation of Rosuvastatin and Its Complete Impurity Profile in Tablet Formulations |
MOLECULES |
2023 |
| Targeting the Grb2 cSH3 domain: design, synthesis and biological evaluation of the first series of modulators |
BIOORGANIC CHEMISTRY |
2023 |
| Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as an Anticancer Agent |
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE |
2023 |
| Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment |
MOLECULES |
2023 |
| Rimonabant-Based Compounds Bearing Hydrophobic Amino Acid Derivatives as Cannabinoid Receptor Subtype 1 Ligands |
ACS MEDICINAL CHEMISTRY LETTERS |
2023 |
| 4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells |
JOURNAL OF MEDICINAL CHEMISTRY |
2023 |
| Biological evaluation of [4‐(4‐aminophenyl)‐1‐(4‐fluorophenyl)‐1H‐pyrrol‐3‐yl](3,4,5‐trimethoxyphenyl)methanone as potential antineoplastic agent in 2D and 3D breast cancer models |
ARCHIV DER PHARMAZIE |
2023 |
| Anticancer activity of (S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyridin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide (RS4690), a new dishevelled 1 inhibitor |
CANCERS |
2022 |
| Single-run chemo- and enantio-selective high-performance liquid chromatography separation of tramadol and its principal metabolite, O-desmethyltramadol, using a chlorinated immobilized amylose-based chiral stationary phase under multimodal elution conditions |
SEPARATION SCIENCE PLUS |
2022 |
| Modulating undruggable targets to overcome cancer therapy resistance |
DRUG RESISTANCE UPDATES |
2022 |
| Exploring CCRL2 chemerin binding using accelerated molecular dynamics |
PROTEINS |
2022 |
| Discovery of novel human lactate dehydrogenase inhibitors: Structure-based virtual screening studies and biological assessment |
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY |
2022 |
| EFFICACY AND SAFETY OF A NOVEL FOOD SUPPLEMENT IN THE TREATMENT OF FUNCTIONAL DYSPEPSIA: A PILOT OPEN STUDY |
AGRO FOOD INDUSTRY HI-TECH |
2022 |
| Induction of Ferroptosis in Glioblastoma and Ovarian Cancers by a New Pyrrole Tubulin Assembly Inhibitor |
JOURNAL OF MEDICINAL CHEMISTRY |
2022 |
